Committee for Orphan Medicinal Products (COMP): 17-19 May 2016

• Date:
  Tuesday, 17 May 2016, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

Documents

Minutes of the COMP meeting 17-19 May 2016

AdoptedReference Number: EMA/COMP/339164/2016

COMP meeting report on the review of applications for orphan designation: May 2016

Reference Number: EMA/COMP/331689/2016Summary:

The COMP adopted 19 positive opinions recommending the following medicines for designation as orphan medicinal products to the European Commission (EC).

Agenda - COMP agenda of the 17-19 May 2016 meeting

DraftReference Number: EMA/COMP/292880/2016Summary:

Committee for Orphan Medicinal Products (COMP) - Draft agenda for the meeting on 17-19 May 2016